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Abstract:  
Objective: To assess the educational needs of people with Ankylosing Spondylitis (AS) 
and Psoriatic Arthritis (PsA), test differences across patient subgroups and identify factors 
independently associated with their educational needs. 
Methods: This was a cross-sectional analytic study. Patients with AS and PsA completed 
the Portuguese version of the Educational Needs Assessment Tool (PortENAT). Data 
were Rasch-transformed before descriptive and inferential analyses were undertaken. 
Univariable and multivariable analyses were used to determine differences between 
patient subgroups and factors independently associated with their educational needs. 
Results: The study included 121 patients with AS and 132 with PsA. The level of 
educational needs varied by diagnostic group, but higher needs for both subgroups were 
reported regarding the “Disease process”, “Feelings” and “Managing pain” domains. 
Overall, patients with AS had a higher level of educational needs than those with PsA. In 
both disease groups, female gender was independently associated with higher educational 
needs. In the PsA group, a shorter disease duration was independently associated with 
higher educational needs in the following domains: “Managing pain”, “Movement” and 
“Feelings”. 
Conclusion: Educational needs vary by diagnostic group, gender and disease duration. 
These differences merit consideration in the design of patient education interventions. 
 
Key words: educational needs assessment, patient education, spondyloarthritis, 
ankylosing spondylitis, psoriatic arthritis. 
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Introduction 
Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) have important and 
multidimensional impacts upon patient´s lives, derived not only from pain, joint 
deformity and work disability but also due to interference in simple daily activities, such 
as self-care (1–3). The holistic management of these conditions involves pharmacological 
(4,5) and non-pharmacological interventions such as healthy lifestyle choices (e.g. 
smoking cessation, weight management and diet), physiotherapy and exercise (4,6,7). 
Patients and health-care professionals have stressed the need for personalisation of 
treatment according to individual needs, values and resources. Patient education plays a 
crucial role in empowering patients as partners in achieving the desirable standards of 
care (8).  
The Educational Needs Assessment Tool was developed in the UK (9) and later 
adapted and validated into Portuguese (PortENAT) (10) and other languages for use in 
seven rheumatic diseases, including AS and PsA (11). The clinical utility of this tool has 
been evaluated by patients and clinicians (12) and it has been shown to help deliver 
effective needs-based patient education in rheumatoid arthritis (RA) (13). 
Three studies have summarised the educational needs of patients with 
Spondyloarthritis (SpA) (14–16). Two (14,15) were conducted in Sweden and one in 
Austria (16). One (14) found that patients with SpA (AS and undifferentiated 
Spondyloarthritis - USpA) had considerable educational needs, especially concerning 
“Self-help”, “Feelings”, and the “Disease process”; and the other (15) validated ENAT to 
assess educational needs in USpA, and showed that higher disease activity was associated 
with higher levels of educational needs. The Austrian study (16), showed that educational 
needs vary by diagnostic group (PsA, RA, and osteoarthritis), disease activity and 
personal characteristics. The results of the above studies are interesting but may not be 
 4 
generalizable to other countries, due to differences in culture, healthcare systems and the 
way patient education is delivered. In addition, none of them assessed the factors 
independently associated with educational needs, using multivariable analyses.  
The objectives of this study were to (i) assess the self-reported educational needs 
of patients with AS and PsA, (ii) study the differences between patient subgroups and (iii) 
identify factors independently associated with educational needs in patients with these 
conditions. 
 
Materials and methods 
Study design and settings 
This was a cross-sectional study carried out in an outpatient clinic of a university hospital 
in the centre region of Portugal. The study was conducted in accordance with the 
declaration of Helsinki and was approved by the local ethics committee (HUC-09-010). 
Voluntary informed consent was obtained from all patients prior to any study procedures. 
 
Participants 
Consecutive patients from the rheumatology clinics meeting the following 
inclusion criteria were invited to participate: (i) age ≥ 18 years old, (ii) a clinical diagnosis 
of AS or PsA by a rheumatologist, and (iii) ability to complete the questionnaire unaided. 
The exclusion criteria were (i) having any other clinically significant comorbid rheumatic 
disease, (ii) unwillingness to participate.  
 
Assessments 
All participants completed the PortENAT in its original form, i.e., the Portuguese 
version of ENAT used for European validation of this tool (10). This questionnaire 
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contains 39 items, grouped into 7 domains: “Managing pain” (7 items), “Movement” (5 
items), “Feelings” (4 items), “Disease process” (7 items), “Treatments” (7 items), “Self-
help measures” (6 items), and “Support systems” (4 items). Each item is assessed using a 
0-4 Likert Scale from “not at all important” to “extremely important”. This gives a total 
score range of 0 to 156, higher scores representing higher educational needs.  
From the first page of PortENAT we collected patient-reported information about 
personal characteristics (age, gender, disease duration (years) and educational 
background (three ordinal options: basic, secondary or higher)) plus an indication of their 
overall needs for information about their rheumatic disease (four ordinal options from “I 
do not want to know anything” to “I want to know everything”). Further details of the 
PortENAT and its validation can be found elsewhere (10). Patients completed the 
PortENAT before a regular clinic appointment.  
 
Data Analysis 
Following completion of the PortENAT, the raw scores were transformed into 
interval-level data (ordinal-to-interval measure conversion table is published elsewhere 
(10)) and summarised descriptively before further analyses. As the ENAT domains have 
different maximum scores, mean percentages of the maximum score were determined and 
used to compare between domains. 
For univariable analyses, we used independent t-tests to evaluate differences in 
educational needs between gender (female vs male) and educational background (patients 
with “basic education” vs those with “secondary or higher education”). To investigate the 
relationship between educational needs and the independent continuous variables (age 
and disease duration) correlation statistics were used.  
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Multivariable analyses (multiple linear regression, enter method) were performed 
for each disease, using PortENAT scores (domain and total scores) as dependent variables 
and forcing age (years, continuous), gender (female vs male), educational background 
(“basic education” vs “secondary or higher education”) and disease duration (years, 
continuous) in the model as theoretically important independent variables. 
We present parameter estimates with their associated 95% confidence intervals (CI) 
and p-values. Results were considered statistically significant for p-values <0.05. We 
used IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp. in all 
analyses. 
 
Results 
Population characteristics 
Table I presents the demographic and needs of information for each diagnostic 
group. Of the 280 patients that were invited, 253 returned the questionnaire (90.4% 
response rate), 121 with AS and 132 with PsA. The rate of complete data (no missing 
items) was 91.7% (n=111) and 88.6% (n=117) in the AS and PsA groups, respectively. 
Responses to the screening question indicated that the majority of patients wanted to 
know “everything” about their disease and only 6.7% and 10.9% of patients with AS and 
PsA, indicated that they did not want any information.  
 
Comparison of educational needs by diagnostic group  
Table II presents the scores of educational needs by diagnostic group. Patients with 
AS expressed, overall, a higher level of educational needs than those with PsA, reaching 
statistical significance in the domains of “Treatments”, “Self-help measures” and 
“Support systems”.  
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Associations of educational needs with socio-demographic factors and disease 
characteristics (univariable analyses) 
Table III presents the results of the univariable analyses in each diagnostic group: 
(III. a.) differences in perceived educational needs by gender and educational 
background; (III. b.) correlation between educational needs and age or disease duration. 
Significant differences are outlined below: 
In AS: 
Gender: Female patients had higher educational needs than their male 
counterparts in the domains of “Feelings”, “Self-help measures”, “Managing pain” and 
“Movement”. 
Educational background: Patients with a lower educational background had 
higher educational needs than their counterparts on the domains of “Movement” and 
“Feelings”. 
Age: A significant negative correlation was found between age and educational 
needs on the domain of “Self-help measures”: being young was weakly correlated (r=-
0.25) to having higher educational needs.  
 
In PsA: 
Gender: Female patients had higher educational needs than their male 
counterparts in the domains of “Feelings”, “Self-help measures” and “Disease Process”. 
Educational background: Patients with higher educational background had higher 
educational needs than their counterparts regarding “Feelings” and “Self-help measures”. 
Age: negative significant weak correlations (0.2 < r < 0.3) were found between 
age and educational needs on “Managing pain”, “Disease process” and “Self-help 
measures” domains. 
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Disease duration: having shorter disease duration was weakly but significantly 
correlated (0.2 < r < 0.3) with higher educational needs regarding “Managing pain”, 
“Movement”, “Disease process” and “Self-help measures”. 
Factors independently associated with educational needs (multivariable analyses) 
Results of multiple linear regression analyses are presented in Table IV. 
In AS, gender was independently associated with educational needs: being female 
was independently associated with high educational needs on the domains of “Managing 
pain”, “Movement” and “Feelings”.  Age, disease duration and educational background 
were not independently associated with educational needs on any domain.  
In PsA, being female was independently associated with higher educational needs 
in the domain of “Feelings” and having shorter disease duration was independently 
associated with higher educational needs on the domains of “Managing pain”, 
“Movement” and “Disease Process”. Age and educational background were no longer 
associated with educational needs on any domain. 
 
 
Discussion 
AS and PsA are the two best-studied SpA subtypes so far (17), notwithstanding little 
is known about the educational needs of these patients, as only a few publications have 
addressed this topic (14,16). Our cross-sectional study suggests that these patients have 
important educational needs, which vary by diagnostic group. The main factors 
independently associated with educational needs were gender in both AS and PsA and 
disease duration in PsA. 
Patients with AS reported, overall, a higher level of educational needs than those 
with PsA (Table II). The reasons underlying these differences are not clear. Our results 
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suggest that the content of educational interventions should pay special attention to 
“Disease process”, “Feelings” and “Managing pain” in both AS and PsA, as these 
domains were considered more important than others. As participants with AS had higher 
educational needs than those with PsA (“Treatments”, “Self-help measures” and “Support 
systems”) perhaps educational interventions for the two diagnostic groups should be 
separate (disease-specific). Nevertheless, as our study was performed using the data 
collected in the context of the European validation of ENAT tool (not designed to 
formally compare diagnostic groups), these differences between AS and PsA need further 
confirmation, particularly, in studies ensuring comparability of cohorts regarding other 
factors potentially influencing educational needs (e.g. disease activity). 
After considering all factors in multivariable analyses (Table IV), only gender and 
disease duration remained independently associated with educational needs. Gender was 
the only factor independently associated with educational needs in both diagnostic 
groups. This association was more evident in AS, where being female was independently 
associated with higher educational needs in three domains: “Managing pain”, 
“Movement” and “Feelings”. Other international studies using the ENAT have reported 
similar gender differences in AS and PsA (11, 13), although they were based on 
univariable analyses only. Our data add robustness to this evidence by controlling for 
other factors. Recent evidence suggests that female patients with AS have functional MRI 
signals consistent with central chronic pain (18). Together with our findings, this 
highlights the special importance of addressing “Managing pain” in patient education for 
patient subgroup. In PsA, being female was independently associated with higher 
educational needs on the “Feelings” domain only.  
In the PsA dataset, disease duration was independently associated with educational 
needs:  shorter disease duration was associated with higher levels of educational needs in 
 10 
“Managing pain”, “Movement” and “Disease process” domains, mirroring the 
associations found in the univariable analysis. Previous studies reported no association 
between disease duration and educational needs in AS and PsA (14,16). However, this 
may be explained by methodological limitations of those studies as they used univariable 
analysis only and disease duration was dichotomized as shorter/longer  (cut-off of ≤/> 10 
years in AS (14) and ≤/> 25th percentile of disease duration in PsA (16)). Our study used 
multivariable analyses and disease duration was analysed as a continuous variable (i.e. 
taking advantage of the entire scale), thus providing more robust conclusions. 
Strengths of our study are: the few missing data; the use of an instrument (ENAT 
questionnaire) with strong construct validity and reliability, cross-cultural validity, 
allowing for cross-cultural comparisons (11); age and disease duration were included in 
the analysis as continuous variables, taking advantage of the entire scale, instead of 
“artificially” creating cut-offs to dichotomize these variables; and, for the first time, the 
use of multivariable analysis to determine factors independently associated with 
educational needs in AS and PsA.  
Our results should be interpreted in the light of some limitations. Data were collected 
from a sample of patients attending one single centre, which limits the generalisability of 
the results. However, as the socio-demographic features are in agreement with 
expectations for AS and PsA populations (19), our results are likely to provide relevant 
information at group-level for both diseases, at least in Portugal. Some possible 
determinants of educational needs, such as disease activity, physical function, 
comorbidities, treatment, economic status, family support and pre-existing knowledge of 
the patients were not addressed. Future research should take these factors into account.  
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In conclusion, our results suggest that educational needs vary by diagnostic group, 
gender and disease duration. Educators should be aware of these differences and target 
resources appropriately. 
 
Contributors AM and PMM collected the data. MN, MLM and RJOF designed the study. 
MLM and RJOF analysed the data. MLM prepared the first version of the manuscript. 
MN and JAPS supervised and contributed to all steps of the work. All authors critically 
interpreted the results, reviewed the draft versions and gave their approval of the final 
version of the manuscript. 
 
Acknowledgments/Funding This study was supported by a research grant from 
European League Against Rheumatism Standing Committee of Health Professionals 
(Grant reference HPR011). Pedro M Machado is supported by the National Institute for 
Health Research (NIHR) University College London Hospitals (UCLH) Biomedical 
Research Centre (BRC). The views expressed are those of the authors and not necessarily 
those of the (UK) National Health Service (NHS), the NIHR, or the (UK) Department of 
Health. 
 
Competing interests None. 
 
References 
1.  Lebwohl MG, Bachelez H, Barker J, Girolomoni G, Kavanaugh A, Langley RG, 
et al. Patient perspectives in the management of psoriasis: results from the 
population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis 
Survey. J Am Acad Dermatol [Internet]. 2014 May [cited 2017 Sep 
15];70(5):871-81.e1-30. Available from: 
 12 
http://linkinghub.elsevier.com/retrieve/pii/S0190962214009773 
2.  Roussou E, Sultana S. The Bath Ankylosing Spondylitis Activity and Function 
Indices (BASDAI and BASFI) and their correlation with main symptoms 
experienced by patients with spondyloarthritis. Clin Rheumatol [Internet]. 2010 
Aug 14 [cited 2017 Sep 15];29(8):869–74. Available from: 
http://link.springer.com/10.1007/s10067-010-1411-9 
3.  Kavanaugh A, Helliwell P, Ritchlin CT. Psoriatic Arthritis and Burden of 
Disease: Patient Perspectives from the Population-Based Multinational 
Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Rheumatol Ther 
[Internet]. 2016 Jun 29 [cited 2017 Sep 15];3(1):91–102. Available from: 
http://link.springer.com/10.1007/s40744-016-0029-z 
4.  van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, 
Sepriano A, et al. 2016 update of the ASAS-EULAR management 
recommendations for axial spondyloarthritis. Ann Rheum Dis [Internet]. 2017 
Jun [cited 2017 Sep 15];76(6):978–91. Available from: 
http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2016-210770 
5.  Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, et al. 
European League Against Rheumatism (EULAR) recommendations for the 
management of psoriatic arthritis with pharmacological therapies: 2015 update. 
Ann Rheum Dis [Internet]. 2016 Mar [cited 2017 Sep 15];75(3):499–510. 
Available from: http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2015-
208337 
6.  Reimold AM, Chandran V. Nonpharmacologic therapies in spondyloarthritis. 
Best Pract Res Clin Rheumatol [Internet]. 2014 Oct [cited 2017 Sep 
16];28(5):779–92. Available from: 
 13 
http://linkinghub.elsevier.com/retrieve/pii/S1521694214000850 
7.  van den Berg R, Baraliakos X, Braun J, van der Heijde D. First update of the 
current evidence for the management of ankylosing spondylitis with non-
pharmacological treatment and non-biologic drugs: a systematic literature review 
for the ASAS/EULAR management recommendations in ankylosing spondylitis. 
Rheumatology (Oxford) [Internet]. 2012 Aug [cited 2017 Sep 16];51(8):1388–
96. Available from: https://academic.oup.com/rheumatology/article-
lookup/doi/10.1093/rheumatology/kes066 
8.  Zangi HA, Ndosi M, Adams J, Andersen L, Bode C, Bostrom C, et al. EULAR 
recommendations for patient education for people with inflammatory arthritis. 
Ann Rheum Dis. England; 2015 Jun;74(6):954–62.  
9.  Towards the development of a tool to assess educational needs in patients with 
arthritis. Clin Eff Nurs [Internet]. Churchill Livingstone; 2004 Jun 1 [cited 2017 
Sep 16];8(2):111–7. Available from: 
http://www.sciencedirect.com/science/article/pii/S1361900404000238 
10.  Cruz A, Machado P, Hill J, Campos M, Apóstolo J, Marques A, et al. Cross-
cultural validation of the portuguese version of the Educational Needs 
Assessment Tool ( PORTENAT ). Acta Reum Port. 2015;40:242–53.  
11.  Ndosi M, Bremander A, Hamnes B, Horton M, Kukkurainen ML, Machado P, et 
al. Validation of the educational needs assessment tool as a generic instrument 
for rheumatic diseases in seven European countries. Ann Rheum Dis. England; 
2014 Dec;73(12):2122–9.  
12.  Hardware B, Johnson D, Hale C, Ndosi M, Adebajo A. Patients and nursing staff 
views of using the education needs assessment tool in rheumatology clinics: a 
qualitative study. J Clin Nurs [Internet]. 2015 Apr [cited 2017 Sep 16];24(7–
 14 
8):1048–58. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25422168 
13.  Ndosi M, Johnson D, Young T, Hardware B, Hill J, Hale C, et al. Effects of 
needs-based patient education on self-efficacy and health outcomes in people 
with rheumatoid arthritis: a multicentre, single blind, randomised controlled trial. 
Ann Rheum Dis [Internet]. 2016 Jun [cited 2017 Sep 16];75(6):1126–32. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26162769 
14.  Haglund E, Bremander A, Bergman S, Larsson I. Educational needs in patients 
with spondyloarthritis in Sweden – a mixed-methods study. BMC Musculoskelet 
Disord [Internet]. 2017 Dec 2 [cited 2017 Sep 16];18(1):335. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/28768510 
15.  Bremander A, Haglund E, Bergman S, Ndosi M. The educational needs of 
patients with undifferentiated spondyloarthritis: Validation of the ENAT 
questionnaire and needs assessment. Musculoskeletal Care. England; 2018 
Jun;16(2):313–7.  
16.  Drăgoi RG, Ndosi M, Sadlonova M, Hill J, Duer M, Graninger W, et al. Patient 
education, disease activity and physical function: can we be more targeted? A 
cross sectional study among people with rheumatoid arthritis, psoriatic arthritis 
and hand osteoarthritis. Arthritis Res Ther [Internet]. 2013 Oct 20 [cited 2017 
Sep 16];15(5):R156. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/24286444 
17.  Baeten D, Breban M, Lories R, Schett G, Sieper J. Are spondylarthritides related 
but distinct conditions or a single disease with a heterogeneous phenotype? 
Arthritis Rheum [Internet]. 2013 Jan [cited 2017 Sep 16];65(1):12–20. Available 
from: http://doi.wiley.com/10.1002/art.37829 
18.  Rogachov A, Cheng JC, Hemington KS, Bosma RL, Kim JA, Osborne NR, et al. 
 15 
Abnormal Low-Frequency Oscillations Reflect Trait-Like Pain Ratings in 
Chronic Pain Patients Revealed through a Machine Learning Approach. J 
Neurosci. United States; 2018 Aug;38(33):7293–302.  
19.  Stolwijk C, van Onna M, Boonen A, van Tubergen A. Global Prevalence of 
Spondyloarthritis: A Systematic Review and Meta-Regression Analysis. Arthritis 
Care Res (Hoboken) [Internet]. 2016 Sep [cited 2017 Sep 15];68(9):1320–31. 
Available from: http://doi.wiley.com/10.1002/acr.22831 
 16 
Table I. Demographic and self-perceived information needs by diagnostic group. 
  
AS 
(n=121) 
PsA 
(n=132) 
Male, n (%)  70 (57.9) 65 (49.2) 
Age, years, mean (SD)  47.3 (13.2) 53.8 (12.8) 
Disease duration*, years, mean (SD)  15.6 (11.8) 14.4 (10.2) 
Educational background* Basic, n (%) 33 (27.7) 65 (52.8) 
 Secondary, n (%) 62 (52.1) 45 (36.6) 
 Higher, n (%) 24 (20.2) 13 (10.6) 
How much information?* None, n (%) 8 (6.7) 14 (10.9) 
 Some things, n (%) 22 (18.3) 40 (31.3) 
 A lot of things, n (%) 16 (13.3) 13 (10.2) 
 Everything, n (%) 74 (61.7) 61 (47.7) 
 
AS, Ankylosing Spondylitis; PsA, Psoriatic Arthritis; SD, standard deviation  
*Percentages of patients with missing data were ≤3.0%, except for Educational background in patients with 
PsA (6.8%) and Disease duration in AS (6.6%) and PsA (9.1%). 
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Table II. Comparison of educational needs between patients with AS and PsA.  1 
 AS (n=121) PsA (n=132) Difference 
Domain (score range)# N Mean (SD)** Mean as % of 
maximum## 
N Mean (SD)** Mean as % of 
maximum 
MD (95% CI) t-statistic p-value 
1. Managing pain (0-24) 121 14.3 (5.2) 59.6% 130 13.3 (6.4) 55.4% 1.00 (-0.46 to 2.46) 1.360 0.175 
2. Movement (0-20) 121 10.6 (3.8) 53.0% 131 10.5 (4.8) 52.5% 0.12 (-0.95 to 1.19) 0.227 0.821 
3. Feelings (0-16) 121 9.5 (3.8) 59.4% 130 9.5 (3.5) 59.4% 0.05 (-0.86 to 0.96) 0.108 0.914 
4. Disease process (0-28) 121 18.2 (5.5) 65.0% 130 17.6 (6.2) 62.9% 0.58 (-0.88 to 2.04) 0.786 0.433 
5. Treatments (0-28) 112 14.6 (5.2) 52.1% 119 12.9 (5.2) 46.1% 1.68 (0.32 to 3.03) 2.444 0.015 
6. Self-help measures (0-24) 121 14.8 (5.3) 61.7% 131 12.8 (6.1) 53.3% 1.98 (0.57 to 3.40) 2.759 0.006 
7. Support systems (0-16) 120 9.3 (3.6) 58.1% 131 7.3 (3.8) 45.6% 2.00 (1.08 to 2.92) 4.284 <0.001 
Total PortENAT score (0-156) 111 88.6 (23.2) 56.8% 117 79.7 (26.4) 51.1% 8.88 (2.37 to 15.39) 2.688 0.008 
# Higher scores mean higher level of educational needs.  2 
## Determined as: (mean value of the domain*100) / maximum value of the domain. This percentage allows easier comparison between domains. 3 
AS, Ankylosing Spondylitis; PsA, Psoriatic Arthritis; MD, mean difference (AS scores minus PsA scores); PortENAT, Portuguese Educational Needs Assessment Tool. 4 
**Rasch-transformed PortENAT scores. 5 
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Table III. Educational needs of both diagnostic groups by gender, educational background, age and disease duration (univariable analyses).  
 
III. a. Comparison of educational needs in each diagnostic group by gender and educational background.  
ENAT Domains (range) 
Pain 
(0-24) 
Movement 
(0-20) 
Feelings 
(0-16) 
Disease process 
(0-28) 
Treatments 
(0-28) 
Self-help 
(0-24) 
Support 
(0-16) 
Total score 
(0-164) 
AS 
Gender 
Male, mean (SD) 13.3 (4.8) 9.7 (3.6) 8.6 (3.8) 17.6 (5.6) 14.0 (5.1) 14.0 (5.2) 8.8 (3.6) 83.4 (23.1) 
Female, mean (SD) 15.6 (5.5) 11.8 (3.9) 10.9 (3.3) 19.1 (5.5) 15.4 (5.2) 16.0 (5.3) 10.1 (3.5) 96.0 (21.5) 
p-value 0.013 0.004 <0.001 0.148 0.154 0.039 0.053 0.004 
Educational 
background 
Basic, mean (SD) 13.6 (3.9) 11.0 (3.3) 10.6 (3.1) 17.6 (5.6) 15.5 (3.9) 13.2 (4.6) 9.6 (3.2) 89.6 (18.4) 
Above*, mean (SD) 14.5 (5.9) 8.6 (3.7) 8.0 (4.2) 17.8 (5.2) 12.9 (6.5) 14.4 (6.2) 8.2 (3.1) 82.2 (26.5) 
p-value 0.498 0.012 0.009 0.888 0.076 0.415 0.098 0.228 
PsA 
Gender 
Male, mean (SD) 12.3 (6.5) 10.0 (4.8) 8.3 (3.3) 16.5 (6.1) 12.8 (5.3) 11.5 (6.3) 6.6 (3.5) 75.8 (28.6) 
Female, mean (SD) 14.0 (6.0) 10.8 (4.6) 10.6 (3.3) 18.6 (6.0) 13.0 (5.2) 14.0 (5.5) 7.9 (3.9) 83.7 (23.6) 
p-value 0.121 0.312 <0.001 0.048 0.839 0.018 0.056 0.102 
Educational 
background 
Basic, mean (SD) 11.9 (6.9) 9.7 (5.0) 9.0 (3.6) 17.2 (6.6) 12.5 (5.4) 11.7 (6.3) 7.3 (4.3) 73.6 (26.7) 
Above*, mean (SD) 15.7 (5.7) 12.4 (4.3) 11.4 (4.8) 17.0 (6.1) 14.0 (7.2) 16.8 (6.1) 6.7 (3.4) 93.9 (32.9) 
p-value 0.068 0.073 0.043 0.918 0.405 0.008 0.672 0.021 
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III. b. Correlation between educational needs, age and disease duration by diagnostic group. 
ENAT Domains (range) 
Pain 
(0-24) 
Movement 
(0-20) 
Feelings 
(0-16) 
Disease process 
(0-28) 
Treatments 
(0-28) 
Self-help 
(0-24) 
Support 
(0-16) 
Total score 
(0-164) 
AS 
Age 
r -0.01 0.15 0.02 -0.12 -0.14 -0.25 -0.03 -0.13 
p-value 0.992 0.114 0.846 0.200 0.163 0.007 0.764 0.193 
Disease 
duration 
r 0.03 0.05 0.02 -0.05 -0.13 -0.14 0.01 -0.07 
p-value 0.778 0.638 0.822 0.582 0.179 0.150 0.960 0.481 
PsA 
Age 
r -0.22 -0.17 -0.14 -0.23 -0.13 -0.26 0.03 -0.28 
p-value 0.015 0.063 0.109 0.009 0.163 0.004 0.758 0.002 
Disease 
duration 
r 0.28 -0.28 -0.14 -0.27 -0.12 -0.25 -0.03 -0.33 
p-value 0.002 0.002 0.135 0.003 0.204 0.006 0.740 0.001 
AS, Ankylosing Spondylitis; ENAT, Educational Needs Assessment Tool; PsA, Psoriatic Arthritis; r- Pearson's correlation.  
*secondary or higher education 
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Table IV. Multiple linear regression analysis of educational needs (transformed Port-ENAT scores) and all independent variables. 
 IV. a. Ankylosing Spondylitis (AS) 
Independent 
variables 
Reference 
category 
Pain 
(0-24) 
Movement 
(0-20) 
Feelings 
(0-16) 
Disease Process 
(0-28) 
Treatments 
(0-28) 
Self-Help 
(0-24) 
Support 
(0-16) 
Total ENAT Score 
(0-164) 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
Gender Male 
0.28 
0.87 to 
5.07 
0.006 
0.81 
0.81 to 
3.84 
0.003 
0.32 
1.00 to 
3.94 
0.001 
0.17 
-0.34 to 
4.10 
0.096 
0.10 
-1.18 to 
3.33 
0.345 
0.17 
-0.22 to 
4.02 
0.078 
0.17 
-0.21 to 
2.67 
0.093 
0.25 
2.38 to 
22.42 
0.016 
Educational 
background 
Basic 
0.09 
-1.62 to 
3.75 
0.433 
0.03 
-1.65 to 
2.24 
0.762 
-0.20 
-3.72 to 
0.05 
0.056 
0.01 
-2.70 to 
2.99 
0.921 
-0.21 
-5.42 to 
0.26 
0.074 
0.10 
-1.44 to 
3.99 
0.355 
-0.10 
-2.67 to 
1.00 
0.370 
-0.11 
-18.54 to 
6.61 
0.349 
Disease 
duration # 
 
-0.01 
-0.10 to 
0.09 
0.924 
-0.08 
-0.10 to 
0.05 
0.474 
-0.01 
-0.07 to 
0.06 
0.896 
0.03 
-0.09 to 
0.12 
0.816 
-0.09 
-0.14 to 
0.06 
0.459 
-0.02 
-0.11 to 
0.09 
0.856 
-0.03 
-0.08 to 
0.06 
0.787 
-0.04 
-0.53 to 
0.37 
0.737 
Age #  
0.11 
-0.06 to 
0.14 
0.394 
0.26 
-0.01 to 
0.15 
0.054 
0.00 
-0.07 to 
0.07 
0.998 
-0.05 
-0.13 to 
0.08 
0.694 
-0.18 
-0.18 to 
0.04 
0.197 
-0.13 
-0.15 to 
0.05 
0.286 
0.01 
-0.07 to 
0.07 
0.961 
-0.08 
-0.62 to 
0.32 
0.540 
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IV. b. Psoriatic arthritis (PsA) 
 
 
 
CI, Confidence interval; ENAT, Educational Needs Assessment Tool; AS, Ankylosing Spondylitis; PsA, Psoriatic Arthritis.  
# Defined as a continuous variable. 
Independent 
variables 
Reference 
category 
Pain 
(0-24) 
Movement 
(0-20) 
Feelings 
(0-16) 
Disease Process 
(0-28) 
Treatments 
(0-28) 
Self-Help 
(0-24) 
Support 
(0-16) 
Total ENAT Score 
(0-164) 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
β 
95%CI 
p 
Gender Male 
0.11 
-1.05 to 
3.94 
0.252 
0.02 
-1.66 to 
2.10 
0.817 
0.34 
1.05 to 
3.72 
0.001 
0.14 
-0.66 to 
4.15 
0.153 
-0.10 
-3.35 to 
1.27 
0.373 
0.13 
-0.72 to 
3.93 
0.174 
0.17 
-0.23 to 
2.78 
0.097 
0.04 
-8.86 to 
12.92 
0.712 
Educational 
background 
Basic 
0.14 
-1.21 to 
4.71 
0.244 
0.12 
-1.14 to 
3.34 
0.331 
0.13 
-0.71 to 
2.48 
0.273 
-0.07 
-3.72 to 
2.01 
0.555 
-0.02 
-2.87 to 
2.51 
0.897 
0.16 
-0.84 to 
4.70 
0.169 
-0.02 
-1.97 to 
1.62 
0.848 
0.07 
-8.76 to 
16.59 
0.541 
Age #  
0.01 
-0.12 to 
0.12 
0.969 
0.01 
-0.08 to 
0.10 
0.831 
0.02 
-0.04 to 
0.09 
0.460 
-0.07 
-0.15 to 
0.08 
0.572 
-0.03 
-0.14 to 
0.07 
0.547 
-0.06 
-0.14 to 
0.08 
0.626 
0.03 
-0.06 to 
0.08 
0.804 
-0.08 
-0.65 to 
0.35 
0.545 
Disease 
duration # 
 
-0.23 
-0.26 to    -
0.01 
0.030 
-0.25 
-0.21 to       
-0.02 
0.017 
-0.10 
-0.10 to 
0.03 
0.324 
-0.26 
-0.28 to     -
0.04 
0.012 
-0.11 
-0.17 to 
0.06 
0.333 
-0.18 
-0.23 to 
0.01 
0.069 
-0.02 
-0.08 to 
0.07 
0.882 
-0.28 
-1.24 to 
-0.17 
0.010 
